FPR3 and breast carcinoma: In the same time, flow cytometry results showed that Adriamycin-induced apoptosis in breast cancer cells was significantly increased in both MCF7 and MCF7/ADM cell lines after FPRL2 knockdown (P < 0.0001) (Figures 6C, D).